EFFICIENCY OF DIFFERENT DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN USED TO TREAT ANEMIA IN PREGNANCY
- 作者: Demikhov V.G1, Klimovskaya E.V2, Mirov I.M3, Zhurina O.N1, Golovitsyna O.A1, Morshchakova E.F1
-
隶属关系:
- Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
- City Clinical Hospital Eight, Ryazan
- Academician I.P. Pavlov Ryazan State Medical University
- 期: 编号 1 (2011)
- 页面: 32-35
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246465
- ID: 246465
如何引用文章
详细
全文:
作者简介
V. Demikhov
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
Email: demix777@ya.ru
E. Klimovskaya
City Clinical Hospital Eight, Ryazan
I. Mirov
Academician I.P. Pavlov Ryazan State Medical University
O. Zhurina
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
O. Golovitsyna
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
E. Morshchakova
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
参考
- Демихов В.Г. Этиология и патогенез анемии беременных // Вопр. гематол./онкол. и иммунопатол. в педиатрии. — 2004. — № 1. — С. 36—42.
- Демихов В.Г., Морщакова Е.Ф., Демихова Е.В. и др. Распространенность дефицита железа у беременных женщин // Вопр. гематол./онкол. и иммунопатол. в педиатрии. — 2002. — № 1. — С. 21—23.
- Железодефицитные состояния у беременных и родильниц: Учебное пособие. — М.: «Системные решения». — 2009.
- Румянцев А.Г., Морщакова Е.Ф., Павлов А.Д. Эритропоэтин: биологические свойства, возрастная регуляция эритропоэза, клиническое применение. — М.: ГЭОТАР-МЕД, 2003.
- Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. — М. — 1999. — С. 373—392.
- Alper B.S., Kimber R., Reddy A.K. Using ferritin levels to determine iron-deficiency anemia in pregnancy // J. Fam. Pract. — 2000. — Vol. 49, № 9. — P. 829—832.
- Auerbach M., Ballard H., Trout J.R., et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients withc hemotherapy-related anemia: a multicenter, open-label, randomized trial // J. Clin. Oncol. — 2004. — Vol. 22, № 7. — P. 1301—1307.
- Breymann C., Major A., Richter C. et al. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study // J. Perinat. Med. — 1995. —№ 23. — P. 89—98.
- Centers of Disease Control (CDC). Criteria for anemia in children and childbearing-aged women // Morbidity and Mortal. Wkly Rep. — 1989. — Vol. 38, № 22. — P. 400—404.
- Demikhov V.G., Morshchakova E.F., Pavlov A.D. Update of anemia in pregnancy pathogenesis // Hematologica. — 2005. — Vol. 90, Suppl. 2. — P. 330.
- Hedenus M., Birgegård G., Näsman P. et al. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study // Leukemia. — 2007. — Vol. 21, № 4. — P. 627—632.
- Krafft A., Bencaiova G., Breymann C. Selective use of recombinant human erythropoietin in pregnant patients with sever anemia or nonresponsive to iron sucrose alone // Fetal Diagn. Ther. — 2009. — Vol. 25.— P. 239—245.
- Sifakis S., Pharmakides G. Anemia in pregnancy // Ann. N.Y. Acad. Sci. — 2000. — Vol. 900. — P. 125—136.
- Sifakis S., Angelakis E., Vardaki E. et al. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. // Gynecol. Obstet. Invest. — 2001. — Vol. 51, № 3. — P. 150—156.